Bashan Dror 4
4 · Protalix BioTherapeutics, Inc. · Filed Aug 17, 2023
Insider Transaction Report
Form 4
Bashan Dror
DirectorPRESIDENT AND CEO
Transactions
- Award
Common Stock
2023-08-15+800,000→ 1,885,458 total(indirect: By Trust)
Holdings
- 68,000
Common Stock
Footnotes (2)
- [F1]Represents restricted shares of common stock of Protalix BioTherapeutics, Inc., awarded to the employee under its Amended and Restated 2006 Stock Incentive Plan, as amended. Of such shares, 200,000 shares were fully-vested upon grant and the remaining 600,000 shares vest over a two-year period beginning on the date of grant in eight equal increments on each quarterly anniversary of the date of grant. The restricted shares are subject to accelerated vesting upon a corporate transaction or a change in control as described in the Plan.
- [F2]To qualify for certain tax benefits under Section 102 of the Israeli Tax Ordinance, securities issued to an employee in connection with the Plan must be registered in the name of a trustee.